Edition:
United Kingdom

Adverum Biotechnologies Inc (ADVM.OQ)

ADVM.OQ on NASDAQ Stock Exchange Global Market

3.64USD
7 Dec 2018
Change (% chg)

$0.03 (+0.83%)
Prev Close
$3.61
Open
$3.62
Day's High
$3.67
Day's Low
$3.60
Volume
61,209
Avg. Vol
124,162
52-wk High
$8.55
52-wk Low
$2.62

Chart for

About

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases. Adverum has a robust pipeline that includes product candidates designed to treat rare diseases alpha-1 antitrypsin (A1AT) deficiency and hereditary angioedema (HAE) as well as wet age-related... (more)

Overall

Beta: --
Market Cap(Mil.): $153.67
Shares Outstanding(Mil.): 43.29
Dividend: --
Yield (%): --

Financials

  ADVM.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -1.53 -- --
ROI: -28.12 0.28 15.02
ROE: -29.20 0.94 16.60

Earnings vs. Estimates